# Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

> **NCT06258707** · NA · RECRUITING · sponsor: **Cutting Edge SAS** · enrollment: 58 (estimated)

## Conditions studied

- Aphakia

## Interventions

- **DEVICE:** LuxBoost IOL
- **DEVICE:** LuxGood IOL

## Key facts

- **NCT ID:** NCT06258707
- **Lead sponsor:** Cutting Edge SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-14
- **Primary completion:** 2026-12-15
- **Final completion:** 2027-06-15
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258707, "Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06258707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*